We present a fast sequence with high diagnostic accuracy to move towards high-throughput clinical whole-body cancer staging using PET/MRI. Ferumoxytol-contrast enhanced T1-weighted LAVA-Flex is acquired at 16s/bed, at a voxel size of 3.4x1.5x1.9mm. This contrast-enhanced sequence offers superior vessel contrast and resolution to existing T1 co-registration modalities that are most commonly based on MR attenuation correction sequences or longer T1-weighted sequences. Integration of this sequence in a clinical protocol bears the promise of dramatically accelerated whole-body cancer staging with durations <20min, thus offering similar exam times to the more radiation-invasive alternative of PET/CT.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords